Dec 19 () - BioMarin Pharmaceutical said on Friday it would acquire Amicus Therapeutics for about $4.8 billion, expanding ​its presence in rare metabolic diseases.

BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet

Astrophotographer Josh Dury has captured the beauty of the Geminids in this stunning timelapse exposure.

Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025

Even when information is factually accurate, how it’s presented can introduce subtle biases. As large language models increasingly bring people the news, this bias is a looming problem.

People are getting their news from AI – and it’s altering their views

C-reactive protein – a marker of inflammation – is as easily measured with blood work in a doctor’s office as cholesterol.

How C-reactive protein outpaced ‘bad’ cholesterol as leading heart disease risk marker

NASA's Perseverance Mars rover could break the record for miles driven on another planet

Music is an all inclusive language that resounds with individuals from varying backgrounds. From the musical beats of hip-bounce


LATEST POSTS